The U.S. Food and Drug Administration will meet later this month to consider approval of two bivalent COVID-19 booster vaccines that are reportedly effective against the Omicron variant (B.1.1.529). Both boosters were developed by Moderna and are variations of the company’s original mRNA-1273 vaccine. Read More
COVID-19
Excess mortality during pandemic tops 14 million
May 24, 2022The World Health Organization estimates that excess mortality during the COVID-19 pandemic (2020-2021) globally was 14.91 million. Excess mortality includes reported COVID deaths (5.42 million) as well as unreported COVID deaths, all-cause mortality where COVID played a role, and excess deaths related to healthcare delivery. This methodology was used to more accurately reflect deaths directly and indirectly related to the pandemic. Read More
Neurological sequelae of COVID-19 infection
April 19, 2022A number of recent studies have reported on the incidence of acute neurological complications of COVID-19 infection, as well as long-term complications, variously called PASC (post-acute sequelae of COVID-19) or ‘long COVID’. Data were reported at the American Academy of Neurology annual meeting, held April 2-7 in Seattle, Washington. Read More
AAN 2022 HIGHLIGHTS – TUESDAY, APRIL 5 EDITION
April 5, 2022Selected highlights from the American Academy of Neurology annual meeting, Seattle WA, 2-7 April 2022.
April 6 Edition
April 4 Edition
COVID-19 boosters
MS and pregnancy
First CBT trial for MS fatigue
Clinical practice Read More
AAN 2022 HIGHLIGHTS – MONDAY, APRIL 4 EDITION
April 4, 2022Selected highlights from the American Academy of Neurology annual meeting, Seattle WA, 2-7 April 2022.
April 6 Edition
April 5 Edition
DMTs and vaccine response
Age and outcomes
Biomarkers
Radiologically isolated syndrome (RIS)
Clinical practice Read More